Utility of Common Marmoset (<i>Callithrix jacchus</i>) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug Metabolism

The incidence of liver disease is increasing significantly worldwide and, as a result, there is a pressing need to develop new technologies and applications for end-stage liver diseases. For many of them, orthotopic liver transplantation is the only viable therapeutic option. Stem cells that are cap...

Full description

Bibliographic Details
Main Authors: Rajagopal N. Aravalli, Clifford J. Steer
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/11/7/729
_version_ 1797563686702809088
author Rajagopal N. Aravalli
Clifford J. Steer
author_facet Rajagopal N. Aravalli
Clifford J. Steer
author_sort Rajagopal N. Aravalli
collection DOAJ
description The incidence of liver disease is increasing significantly worldwide and, as a result, there is a pressing need to develop new technologies and applications for end-stage liver diseases. For many of them, orthotopic liver transplantation is the only viable therapeutic option. Stem cells that are capable of differentiating into all liver cell types and could closely mimic human liver disease are extremely valuable for disease modeling, tissue regeneration and repair, and for drug metabolism studies to develop novel therapeutic treatments. Despite the extensive research efforts, positive results from rodent models have not translated meaningfully into realistic preclinical models and therapies. The common marmoset <i>Callithrix jacchus</i> has emerged as a viable non-human primate model to study various human diseases because of its distinct features and close physiologic, genetic and metabolic similarities to humans. <i>C</i>. <i>jacchus</i> embryonic stem cells (cjESC) and recently generated cjESC-derived hepatocyte-like cells (cjESC-HLCs) could fill the gaps in disease modeling, liver regeneration and metabolic studies. They are extremely useful for cell therapy to regenerate and repair damaged liver tissues in vivo as they could efficiently engraft into the liver parenchyma. For in vitro studies, they would be advantageous for drug design and metabolism in developing novel drugs and cell-based therapies. Specifically, they express both phase I and II metabolic enzymes that share similar substrate specificities, inhibition and induction characteristics, and drug metabolism as their human counterparts. In addition, cjESCs and cjESC-HLCs are advantageous for investigations on emerging research areas, including blastocyst complementation to generate entire livers, and bioengineering of discarded livers to regenerate whole livers for transplantation.
first_indexed 2024-03-10T18:46:59Z
format Article
id doaj.art-f42e815f8f0942b4acb9e754162ad8b0
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-10T18:46:59Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-f42e815f8f0942b4acb9e754162ad8b02023-11-20T05:28:12ZengMDPI AGGenes2073-44252020-06-0111772910.3390/genes11070729Utility of Common Marmoset (<i>Callithrix jacchus</i>) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug MetabolismRajagopal N. Aravalli0Clifford J. Steer1Department of Electrical and Computer Engineering, College of Science and Engineering, University of Minnesota, 200 Union Street S.E., Minneapolis, MN 55455, USADepartments of Medicine and Genetics, Cell Biology and Development, University of Minnesota, 420 Delaware Street S.E, Minneapolis, MN 55455, USAThe incidence of liver disease is increasing significantly worldwide and, as a result, there is a pressing need to develop new technologies and applications for end-stage liver diseases. For many of them, orthotopic liver transplantation is the only viable therapeutic option. Stem cells that are capable of differentiating into all liver cell types and could closely mimic human liver disease are extremely valuable for disease modeling, tissue regeneration and repair, and for drug metabolism studies to develop novel therapeutic treatments. Despite the extensive research efforts, positive results from rodent models have not translated meaningfully into realistic preclinical models and therapies. The common marmoset <i>Callithrix jacchus</i> has emerged as a viable non-human primate model to study various human diseases because of its distinct features and close physiologic, genetic and metabolic similarities to humans. <i>C</i>. <i>jacchus</i> embryonic stem cells (cjESC) and recently generated cjESC-derived hepatocyte-like cells (cjESC-HLCs) could fill the gaps in disease modeling, liver regeneration and metabolic studies. They are extremely useful for cell therapy to regenerate and repair damaged liver tissues in vivo as they could efficiently engraft into the liver parenchyma. For in vitro studies, they would be advantageous for drug design and metabolism in developing novel drugs and cell-based therapies. Specifically, they express both phase I and II metabolic enzymes that share similar substrate specificities, inhibition and induction characteristics, and drug metabolism as their human counterparts. In addition, cjESCs and cjESC-HLCs are advantageous for investigations on emerging research areas, including blastocyst complementation to generate entire livers, and bioengineering of discarded livers to regenerate whole livers for transplantation.https://www.mdpi.com/2073-4425/11/7/729livermarmoset<i>Callithrix jacchus</i>embryonic stem celltransplantationhepatocyte
spellingShingle Rajagopal N. Aravalli
Clifford J. Steer
Utility of Common Marmoset (<i>Callithrix jacchus</i>) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug Metabolism
Genes
liver
marmoset
<i>Callithrix jacchus</i>
embryonic stem cell
transplantation
hepatocyte
title Utility of Common Marmoset (<i>Callithrix jacchus</i>) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug Metabolism
title_full Utility of Common Marmoset (<i>Callithrix jacchus</i>) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug Metabolism
title_fullStr Utility of Common Marmoset (<i>Callithrix jacchus</i>) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug Metabolism
title_full_unstemmed Utility of Common Marmoset (<i>Callithrix jacchus</i>) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug Metabolism
title_short Utility of Common Marmoset (<i>Callithrix jacchus</i>) Embryonic Stem Cells in Liver Disease Modeling, Tissue Engineering and Drug Metabolism
title_sort utility of common marmoset i callithrix jacchus i embryonic stem cells in liver disease modeling tissue engineering and drug metabolism
topic liver
marmoset
<i>Callithrix jacchus</i>
embryonic stem cell
transplantation
hepatocyte
url https://www.mdpi.com/2073-4425/11/7/729
work_keys_str_mv AT rajagopalnaravalli utilityofcommonmarmoseticallithrixjacchusiembryonicstemcellsinliverdiseasemodelingtissueengineeringanddrugmetabolism
AT cliffordjsteer utilityofcommonmarmoseticallithrixjacchusiembryonicstemcellsinliverdiseasemodelingtissueengineeringanddrugmetabolism